Nymox Pharmaceutical
NYMX
#9966
Rank
C$25.71 M
Marketcap
Country
$0.28
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -C$2.91 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -C$9.2 Million, an increase over its 2021 earnings that were of -C$17.59 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -C$2.91 Million-68.39%
2022 -C$9.2 Million-47.71%
2021 -C$17.59 Million6.61%
2020 -C$16.5 Million-10.91%
2019 -C$18.52 Million24.24%
2018 -C$14.9 Million-20.03%
2017 -C$18.64 Million2.71%
2016 -C$18.14 Million-63.86%
2015 -C$50.2 Million674.44%
2014 -C$6.49 Million-6.11%
2013 -C$6.91 Million-35.66%
2012 -C$10.74 Million-20.76%
2011 -C$13.55 Million38.33%
2010 -C$9.79 Million35.59%
2009 -C$7.22 Million11.8%
2008 -C$6.46 Million-12.94%
2007 -C$7.42 Million8.85%
2006 -C$6.82 Million36.5%
2005 -C$5 Million-4.4%
2004 -C$5.23 Million-14.58%
2003 -C$6.12 Million
2001 -C$4.49 Million-20.54%
2000 -C$5.65 Million21.72%
1999 -C$4.64 Million-25.56%
1998 -C$6.23 Million101.3%
1997 -C$3.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$9.87 B-324,625.68%๐Ÿ‡บ๐Ÿ‡ธ USA
C$15.65 B-514,352.66%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.65 B-54,472.98%๐Ÿ‡บ๐Ÿ‡ธ USA
C$17.86 B-586,883.90%๐Ÿ‡บ๐Ÿ‡ธ USA
C$24.57 B-807,226.33%๐Ÿ‡บ๐Ÿ‡ธ USA